Publikationer - Övre GI kirurgi

Toppublikationer

Publikationer (n=108) i tidningar med impact factor över 10. Ledande kirurgisk tidsskrift - Annals of Surgery.

Mortality, Reoperation, and Hospital Stay Within 90 Days of Primary and Secondary Antireflux Surgery in a Population-Based Multinational Study.
Yanes M, Santoni G, Maret-Ouda J, Markar S, Ness-Jensen E, Kauppila J, Färkkilä M, Lynge E, Pukkala E, Tryggvadóttir L, von Euler-Chelpin M, Lagergren J
Gastroenterology 2021 Jun;160(7):2283-2290

Association Between Levels of Sex Hormones and Risk of Esophageal Adenocarcinoma and Barrett's Esophagus.
Xie SH, Fang R, Huang M, Dai J, Thrift AP, Anderson LA, Chow WH, Bernstein L, Gammon MD, Risch HA, Shaheen NJ, Reid BJ, Wu AH, Iyer PG, Liu G, Corley DA, Whiteman DC, Caldas C, Pharoah PD, Hardie LJ, Fitzgerald RC, Shen H, Vaughan TL, Lagergren J
Clin Gastroenterol Hepatol 2020 11;18(12):2701-2709.e3

Extent of Lymphadenectomy and Long-Term Survival in Esophageal Cancer.
Gottlieb-Vedi E, Kauppila JH, Mattsson F, Hedberg J, Johansson J, Edholm D, Lagergren P, Nilsson M, Lagergren J
Ann Surg 2021 Jun;():

Risk of Myocardial Infarction, Ischemic Stroke, and Mortality in Patients Who Undergo Gastric Bypass for Obesity Compared With Non-Operated Obese Patients and Population Controls.
Lundberg CE, Björck L, Adiels M, Lagergren J, Rosengren A
Ann Surg 2021 Jul;():

Development and validation of a risk prediction model for esophageal squamous cell carcinoma using cohort studies
Wang Q, Ness-Jensen E, Santoni G, Xie S, Lagergren J
Am J Gastroenterol 2021;116:683-91

Gastroesophageal reflux disease
Maret-Ouda J, Markar SR, Lagergren J
JAMA 2020;324:2536-47

Laryngeal and Pharyngeal Squamous Cell Carcinoma After Antireflux Surgery in the 5 Nordic Countries.
Yanes M, Santoni G, Maret-Ouda J, Ness-Jensen E, Färkkilä M, Lynge E, Pukkala E, Romundstad P, Tryggvadóttir L, von Euler-Chelpin M, Lagergren J
Ann Surg 2020 Oct;():

Risk Factors for Suicide After Bariatric Surgery in a Population-based Nationwide Study in Five Nordic Countries.
Kauppila JH, Santoni G, Tao W, Lynge E, Jokinen J, Tryggvadóttir L, Ness-Jensen E, Pukkala E, von Euler-Chelpin M, Lagergren J
Ann Surg 2020 Jul;():

Hospital Volume of Antireflux Surgery in Relation to Endoscopic and Surgical Re-interventions.
Markar S, Santoni G, Maret-Ouda J, Artama M, Färkkilä M, Lynge E, Pukkala E, Ness-Jensen E, von Euler-Chelpin M, Lagergren J
Ann Surg 2020 Jan;():

Association Between Metformin Use and Risk of Esophageal Squamous Cell Carcinoma in a Population-Based Cohort Study.
Wang QL, Santoni G, Ness-Jensen E, Lagergren J, Xie SH
Am J Gastroenterol 2020 01;115(1):73-78

Reintervention After Antireflux Surgery for Gastroesophageal Reflux Disease in England.
Markar SR, Arhi C, Wiggins T, Vidal-Diez A, Karthikesalingam A, Darzi A, Lagergren J, Hanna GB
Ann Surg 2020 04;271(4):709-715

Circulating Sex Hormone Levels and Risk of Esophageal Adenocarcinoma in a Prospective Study in Men.
Xie SH, Ness-Jensen E, Rabbani S, Langseth H, Gislefoss RE, Mattsson F, Lagergren J
Am J Gastroenterol 2020 02;115(2):216-223

Peptic ulcer disease.
Sverdén E, Agréus L, Dunn JM, Lagergren J
BMJ 2019 Oct;367():l5495

Effects of Obesity Surgery on Overall and Disease-Specific Mortality in a 5-Country Population-Based Study.
Kauppila JH, Tao W, Santoni G, von Euler-Chelpin M, Lynge E, Tryggvadóttir L, Ness-Jensen E, Romundstad P, Pukkala E, Lagergren J
Gastroenterology 2019 07;157(1):119-127.e1

No Association Between Vitamin D Status and Risk of Barrett's Esophagus or Esophageal Adenocarcinoma: A Mendelian Randomization Study.
Dong J, Gharahkhani P, Chow WH, Gammon MD, Liu G, Caldas C, Wu AH, Ye W, Onstad L, Anderson LA, Bernstein L, Pharoah PD, Risch HA, Corley DA, Fitzgerald RC, , Iyer PG, Reid BJ, Lagergren J, Shaheen NJ, Vaughan TL, MacGregor S, Love S, Palles C, Tomlinson I, Gockel I, May A, Gerges C, Anders M, Böhmer AC, Becker J, Kreuser N, Thieme R, Noder T, Venerito M, Veits L, Schmidt T, Schmidt C, Izbicki JR, Hölscher AH, Lang H, Lorenz D, Schumacher B, Mayershofer R, Vashist Y, Ott K, Vieth M, Weismüller J, Nöthen MM, Moebus S, Knapp M, Peters WHM, Neuhaus H, Rösch T, Ell C, Jankowski J, Schumacher J, Neale RE, Whiteman DC, Thrift AP
Clin Gastroenterol Hepatol 2019 10;17(11):2227-2235.e1

Long-term Survival in Esophageal Cancer After Minimally Invasive Compared to Open Esophagectomy: A Systematic Review and Meta-analysis.
Gottlieb-Vedi E, Kauppila JH, Malietzis G, Nilsson M, Markar SR, Lagergren J
Ann Surg 2019 12;270(6):1005-1017

Transcatheter Arterial Embolization Compared With Surgery for Uncontrolled Peptic Ulcer Bleeding: A Population-based Cohort Study.
Sverdén E, Mattsson F, Lindström D, Sondén A, Lu Y, Lagergren J
Ann Surg 2019 02;269(2):304-309

Information on Genetic Variants Does Not Increase Identification of Individuals at Risk of Esophageal Adenocarcinoma Compared to Clinical Risk Factors.
Kunzmann AT, Cañadas Garre M, Thrift AP, McMenamin ÚC, Johnston BT, Cardwell CR, Anderson LA, Spence AD, Lagergren J, Xie SH, Smyth LJ, McKnight AJ, Coleman HG
Gastroenterology 2019 01;156(1):43-45

Assessment of a Noninvasive Exhaled Breath Test for the Diagnosis of Oesophagogastric Cancer.
Markar SR, Wiggins T, Antonowicz S, Chin ST, Romano A, Nikolic K, Evans B, Cunningham D, Mughal M, Lagergren J, Hanna GB
JAMA Oncol 2018 07;4(7):970-976

Model for Identifying Individuals at Risk for Esophageal Adenocarcinoma.
Kunzmann AT, Thrift AP, Cardwell CR, Lagergren J, Xie S, Johnston BT, Anderson LA, Busby J, McMenamin ÚC, Spence AD, Coleman HG
Clin Gastroenterol Hepatol 2018 08;16(8):1229-1236.e4

A seven-Gene Signature assay improves prognostic risk stratification of perioperative chemotherapy treated gastroesophageal cancer patients from the MAGIC trial.
Smyth EC, Nyamundanda G, Cunningham D, Fontana E, Ragulan C, Tan IB, Lin SJ, Wotherspoon A, Nankivell M, Fassan M, Lampis A, Hahne JC, Davies AR, Lagergren J, Gossage JA, Maisey N, Green M, Zylstra JL, Allum WH, Langley RE, Tan P, Valeri N, Sadanandam A
Ann Oncol 2018 12;29(12):2356-2362

Interactions Between Genetic Variants and Environmental Factors Affect Risk of Esophageal Adenocarcinoma and Barrett's Esophagus.
Dong J, Levine DM, Buas MF, Zhang R, Onstad L, Fitzgerald RC, , Corley DA, Shaheen NJ, Lagergren J, Hardie LJ, Reid BJ, Iyer PG, Risch HA, Caldas C, Caldas I, Pharoah PD, Liu G, Gammon MD, Chow WH, Bernstein L, Bird NC, Ye W, Wu AH, Anderson LA, MacGregor S, Whiteman DC, Vaughan TL, Thrift AP
Clin Gastroenterol Hepatol 2018 10;16(10):1598-1606.e4

Risk of Esophageal Adenocarcinoma After Antireflux Surgery in Patients With Gastroesophageal Reflux Disease in the Nordic Countries.
Maret-Ouda J, Wahlin K, Artama M, Brusselaers N, Färkkilä M, Lynge E, Mattsson F, Pukkala E, Romundstad P, Tryggvadóttir L, von Euler-Chelpin M, Lagergren J
JAMA Oncol 2018 11;4(11):1576-1582

Acute upper gastrointestinal bleeding.
Sverdén E, Markar SR, Agreus L, Lagergren J
BMJ 2018 Oct;363():k4023

Information on Genetic Variants Does Not Increase Identification of Individuals at Risk of Esophageal Adenocarcinoma Compared to Clinical Risk Factors.
Kunzmann AT, Cañadas Garre M, Thrift AP, McMenamin ÚC, Johnston BT, Cardwell CR, Anderson LA, Spence AD, Lagergren J, Xie SH, Smyth LJ, McKnight AJ, Coleman HG
Gastroenterology 2019 01;156(1):43-45

Different menopausal hormone regimens and risk of breast cancer.
Brusselaers N, Tamimi RM, Konings P, Rosner B, Adami HO, Lagergren J
Ann Oncol 2018 08;29(8):1771-1776

The Influence of Antireflux Surgery on Esophageal Cancer Risk in England: National Population-based Cohort Study.
Markar SR, Arhi C, Leusink A, Vidal-Diez A, Karthikesalingam A, Darzi A, Lagergren J, Hanna GB
Ann Surg 2018 11;268(5):861-867

Assessing the feasibility of targeted screening for esophageal adenocarcinoma based on individual risk assessment in a population-based cohort study in Norway (The HUNT Study).
Xie SH, Ness-Jensen E, Medefelt N, Lagergren J
Am J Gastroenterol 2018 06;113(6):829-835

Assessment of a Noninvasive Exhaled Breath Test for the Diagnosis of Oesophagogastric Cancer
Markar SR, Wiggins T, Antonowicz S, Chin ST, Romano A, Nikolic K, et al
JAMA Oncol 2018;4:970-976

Determining Risk of Barrett's Esophagus and Esophageal Adenocarcinoma Based on Epidemiologic Factors and Genetic Variants
Dong J, Buas MF, Gharahkhani P, Kendall BJ, Onstad L, Zhao S, et al
Gastroenterology 2018;154:1273-1281.e3

Smoking Cessation and Risk of Esophageal Cancer by Histological Type: Systematic Review and Meta-analysis.
Wang QL, Xie SH, Li WT, Lagergren J
J Natl Cancer Inst 2017 12;109(12):

Helicobacter pylori eradication treatment and the risk of gastric adenocarcinoma in a Western population.
Doorakkers E, Lagergren J, Engstrand L, Brusselaers N
Gut 2018 12;67(12):2092-2096

Transcatheter Arterial Embolization Compared With Surgery for Uncontrolled Peptic Ulcer Bleeding: A Population-based Cohort Study.
Sverdén E, Mattsson F, Lindström D, Sondén A, Lu Y, Lagergren J
Ann Surg 2019 02;269(2):304-309

Association Between Laparoscopic Antireflux Surgery and Recurrence of Gastroesophageal Reflux.
Maret-Ouda J, Wahlin K, El-Serag HB, Lagergren J
JAMA 2017 09;318(10):939-946

The Epidemiology of Esophageal Adenocarcinoma.
Coleman HG, Xie SH, Lagergren J
Gastroenterology 2018 01;154(2):390-405

Oesophageal cancer.
Lagergren J, Smyth E, Cunningham D, Lagergren P
Lancet 2017 Nov;390(10110):2383-2396

Surgeon Age in Relation to Prognosis After Esophageal Cancer Resection.
Markar SR, Mackenzie H, Lagergren P, Lagergren J
Ann Surg 2018 07;268(1):100-105

All-cause and cancer-specific mortality in GORD in a population-based cohort study (the HUNT study).
Ness-Jensen E, Gottlieb-Vedi E, Wahlin K, Lagergren J
Gut 2018 02;67(2):209-215

Mutational signatures in esophageal adenocarcinoma define etiologically distinct subgroups with therapeutic relevance.
Secrier M, Li X, de Silva N, Eldridge MD, Contino G, Bornschein J, MacRae S, Grehan N, O'Donovan M, Miremadi A, Yang TP, Bower L, Chettouh H, Crawte J, Galeano-Dalmau N, Grabowska A, Saunders J, Underwood T, Waddell N, Barbour AP, Nutzinger B, Achilleos A, Edwards PA, Lynch AG, Tavaré S, Fitzgerald RC,
Nat Genet 2016 10;48(10):1131-41

Germline variation in inflammation-related pathways and risk of Barrett's oesophagus and oesophageal adenocarcinoma.
Buas MF, He Q, Johnson LG, Onstad L, Levine DM, Thrift AP, Gharahkhani P, Palles C, Lagergren J, Fitzgerald RC, Ye W, Caldas C, Bird NC, Shaheen NJ, Bernstein L, Gammon MD, Wu AH, Hardie LJ, Pharoah PD, Liu G, Iyer P, Corley DA, Risch HA, Chow WH, Prenen H, Chegwidden L, Love S, Attwood S, Moayyedi P, MacDonald D, Harrison R, Watson P, Barr H, deCaestecker J, Tomlinson I, Jankowski J, Whiteman DC, MacGregor S, Vaughan TL, Madeleine MM
Gut 2017 10;66(10):1739-1747

Genome-wide association studies in oesophageal adenocarcinoma and Barrett's oesophagus: a large-scale meta-analysis
Gharahkhani P, Fitzgerald RC, Vaughan TL, Tomlinson I, Gockel I, Palles C, Buas MF, May A, Gerges C, Anders A, Becker J, Kreuser N, Noder T, Venerito M, Veits L, Schmidt T, Manner H, Schmidt C, Hess T, Böhmer AC, Izbicki JR, Hölscher AH, Lang H, Lorenz D, Schumacher B, Hackelsberger A, Mayershofer R, Pech O, Vashist Y, Ott K, Vieth M, Weismüller J, Nöthen MM, Barrett’s and Esophageal Adenocarcinoma Consortium (BEACON), Wellcome Trust Case Control Consortium 2 (WTCCC2), Attwood S, Barr H, Chegwidden L, deCaestecker J, Harrison R, Love SB, MacDonald D, Moayyedi P, Prenen H, Watson RGP, Iyer PG, Anderson LA, Bernstein L, Chow WH, Hardie LJ, Lagergren J, Liu G, Risch HA, Wu AH, Ye W, Bird NC, Shaheen NJ, Gammon MD, Corley DA, Caldas C, Moebus S, Knapp M, Peters WHM, Neuhaus H, Rösch T, Ell C, MacGregor S, Pharoah P, Whiteman DC, Jankowski J, Schumacher J
Lancet Oncol. 2016;17:1363-73

The Male Predominance in Esophageal Adenocarcinoma.
Xie SH, Lagergren J
Clin Gastroenterol Hepatol 2016 Mar;14(3):338-347.e1

Eradication of Helicobacter pylori and Gastric Cancer: A Systematic Review and Meta-analysis of Cohort Studies.
Doorakkers E, Lagergren J, Engstrand L, Brusselaers N
J Natl Cancer Inst 2016 09;108(9):

Surgical Proficiency Gain and Survival After Esophagectomy for Cancer.
Markar SR, Mackenzie H, Lagergren P, Hanna GB, Lagergren J
J Clin Oncol 2016 05;34(13):1528-36

Weekday of Esophageal Cancer Surgery and Its Relation to Prognosis.
Lagergren J, Mattsson F, Lagergren P
Ann Surg 2016 06;263(6):1133-7

Lifestyle Intervention in Gastroesophageal Reflux Disease.
Ness-Jensen E, Hveem K, El-Serag H, Lagergren J
Clin Gastroenterol Hepatol 2016 Feb;14(2):175-82.e1-3

Antireflux Surgery and Risk of Esophageal Adenocarcinoma: A Systematic Review and Meta-analysis.
Maret-Ouda J, Konings P, Lagergren J, Brusselaers N
Ann Surg 2016 Feb;263(2):251-7

What is the most effective treatment for severe gastro-oesophageal reflux disease?
Maret-Ouda J, Brusselaers N, Lagergren J
BMJ 2015 Jun;350():h3169

Extent of lymph node removal during esophageal cancer surgery and survival.
van der Schaaf M, Johar A, Wijnhoven B, Lagergren P, Lagergren J
J Natl Cancer Inst 2015 May;107(5):

Psychiatric morbidity and survival after surgery for esophageal cancer: a population-based cohort study.
Wikman A, Ljung R, Johar A, Hellstadius Y, Lagergren J, Lagergren P
J Clin Oncol 2015 Feb;33(5):448-54

Ordering of mutations in preinvasive disease stages of esophageal carcinogenesis.
Weaver JMJ, Ross-Innes CS, Shannon N, Lynch AG, Forshew T, Barbera M, Murtaza M, Ong CJ, Lao-Sirieix P, Dunning MJ, Smith L, Smith ML, Anderson CL, Carvalho B, O'Donovan M, Underwood TJ, May AP, Grehan N, Hardwick R, Davies J, Oloumi A, Aparicio S, Caldas C, Eldridge MD, Edwards PAW, Rosenfeld N, Tavaré S, Fitzgerald RC,
Nat Genet 2014 Aug;46(8):837-843

Splenic injury during resection for esophageal cancer: risk factors and consequences.
Derogar M, Sadr-Azodi O, Lagergren P, Lagergren J
Ann Surg 2015 Jan;261(1):111-6

Oesophageal cancer in 2014: Advances in curatively intended treatment.
Lagergren J
Nat Rev Gastroenterol Hepatol 2015 Feb;12(2):74-5

Tumor stage after neoadjuvant chemotherapy determines survival after surgery for adenocarcinoma of the esophagus and esophagogastric junction.
Davies AR, Gossage JA, Zylstra J, Mattsson F, Lagergren J, Maisey N, Smyth EC, Cunningham D, Allum WH, Mason RC
J Clin Oncol 2014 Sep;32(27):2983-90

Tobacco smoking cessation and improved gastroesophageal reflux: a prospective population-based cohort study: the HUNT study.
Ness-Jensen E, Lindam A, Lagergren J, Hveem K
Am J Gastroenterol 2014 Feb;109(2):171-7

British Society of Gastroenterology guidelines on the diagnosis and management of Barrett's oesophagus.
Fitzgerald RC, di Pietro M, Ragunath K, Ang Y, Kang JY, Watson P, Trudgill N, Patel P, Kaye PV, Sanders S, O'Donovan M, Bird-Lieberman E, Bhandari P, Jankowski JA, Attwood S, Parsons SL, Loft D, Lagergren J, Moayyedi P, Lyratzopoulos G, de Caestecker J,
Gut 2014 Jan;63(1):7-42

Clinical management of obese patients with cancer.
Tao W, Lagergren J
Nat Rev Clin Oncol 2013 Sep;10(9):519-33

Association of oral glucocorticoid use with an increased risk of acute pancreatitis: a population-based nested case-control study.
Sadr-Azodi O, Mattsson F, Bexlius TS, Lindblad M, Lagergren J, Ljung R
JAMA Intern Med 2013 Mar;173(6):444-9

Recent developments in esophageal adenocarcinoma.
Lagergren J, Lagergren P
CA Cancer J Clin ;63(4):232-48

Risk factors for esophageal adenocarcinoma after antireflux surgery.
Löfdahl HE, Lu Y, Lagergren P, Lagergren J
Ann Surg 2013 Apr;257(4):579-82

Weight loss and reduction in gastroesophageal reflux. A prospective population-based cohort study: the HUNT study.
Ness-Jensen E, Lindam A, Lagergren J, Hveem K
Am J Gastroenterol 2013 Mar;108(3):376-82

Increased risk of colorectal cancer after obesity surgery.
Derogar M, Hull MA, Kant P, Östlund M, Lu Y, Lagergren J
Ann Surg 2013 Dec;258(6):983-8

Hospital and surgeon volume in relation to survival after esophageal cancer surgery in a population-based study.
Derogar M, Sadr-Azodi O, Johar A, Lagergren P, Lagergren J
J Clin Oncol 2013 Feb;31(5):551-7

Increased risk of Barrett's esophagus among individuals born preterm or small for gestational age.
Forssell L, Cnattingius S, Bottai M, Edstedt Bonamy AK, Lagergren J, Agréus L, Akre O
Clin Gastroenterol Hepatol 2013 Jul;11(7):790-4

Hospital volume, proportion resected and mortality from oesophageal and gastric cancer: a population-based study in England, 2004-2008.
Coupland VH, Lagergren J, Lüchtenborg M, Jack RH, Allum W, Holmberg L, Hanna GB, Pearce N, Møller H
Gut 2013 Jul;62(7):961-6

Vegetables, fruit and risk of non-gallstone-related acute pancreatitis: a population-based prospective cohort study.
Oskarsson V, Sadr-Azodi O, Orsini N, Andrén-Sandberg Å, Wolk A
Gut 2013 Aug;62(8):1187-92

Increased risk of acute pancreatitis among tetracycline users in a Swedish population-based case-control study.
Ljung R, Lagergren J, Bexelius TS, Mattsson F, Lindblad M
Gut 2012 Jun;61(6):873-6

Changes in prevalence, incidence and spontaneous loss of gastro-oesophageal reflux symptoms: a prospective population-based cohort study, the HUNT study.
Ness-Jensen E, Lindam A, Lagergren J, Hveem K
Gut 2012 Oct;61(10):1390-7

Risk of esophagitis among individuals born preterm or small for gestational age.
Forssell L, Cnattingius S, Bottai M, Lagergren J, Ekbom A, Akre O
Clin Gastroenterol Hepatol 2012 Dec;10(12):1369-75

Influence of obesity on the risk of esophageal disorders.
Lagergren J
Nat Rev Gastroenterol Hepatol 2011 Jun;8(6):340-7

Risk of obesity-related cancer after obesity surgery in a population-based cohort study.
Ostlund MP, Lu Y, Lagergren J
Ann Surg 2010 Dec;252(6):972-6

Oesophageal cancer
Lagergren J, Lagergren P
BMJ 2010;341

Novel approach to antibiotic prophylaxis in percutaneous endoscopic gastrostomy (PEG): randomised controlled trial.
Blomberg J, Lagergren P, Martin L, Mattsson F, Lagergren J
BMJ 2010 Jul;341():c3115

The risk of esophageal adenocarcinoma after antireflux surgery.
Lagergren J, Ye W, Lagergren P, Lu Y
Gastroenterology 2010 Apr;138(4):1297-301

Predictors of postoperative quality of life after esophagectomy for cancer.
Djärv T, Blazeby JM, Lagergren P
J Clin Oncol 2009 Apr;27(12):1963-8

Surgeon volume is a poor proxy for skill in esophageal cancer surgery.
Rutegård M, Lagergren J, Rouvelas I, Lagergren P
Ann Surg 2009 Feb;249(2):256-61

Alcohol drinking and the risk of Barrett's esophagus and esophageal adenocarcinoma.
El-Serag HB, Lagergren J
Gastroenterology 2009 Apr;136(4):1155-7

A population-based study showing an association between gastroesophageal reflux disease and sleep problems.
Jansson C, Nordenstedt H, Wallander MA, Johansson S, Johnsen R, Hveem K, Lagergren J
Clin Gastroenterol Hepatol 2009 Sep;7(9):960-5

Postmenopausal hormone therapy as a risk factor for gastroesophageal reflux symptoms among female twins.
Nordenstedt H, Zheng Z, Cameron AJ, Ye W, Pedersen NL, Lagergren J
Gastroenterology 2008 Apr;134(4):921-8

Body Composition and Barrett's Esophagus.
Lagergren J
Gastroenterology 2007 Jul;133(1):343-5

Body measures in relation to gastro-oesophageal reflux.
Lagergren J
Gut 2007 Jun;56(6):741-2

Lifestyle factors and risk for symptomatic gastroesophageal reflux in monozygotic twins.
Zheng Z, Nordenstedt H, Pedersen NL, Lagergren J, Ye W
Gastroenterology 2007 Jan;132(1):87-95

Relation between gastroesophageal reflux symptoms and socioeconomic factors: a population-based study (the HUNT Study).
Jansson C, Nordenstedt H, Johansson S, Wallander MA, Johnsen R, Hveem K, Lagergren J
Clin Gastroenterol Hepatol 2007 Sep;5(9):1029-34

Disparities in the classification of esophageal and cardia adenocarcinomas and their influence on reported incidence rates.
Lindblad M, Ye W, Lindgren A, Lagergren J
Ann Surg 2006 Apr;243(4):479-85

Risk factors for complications after esophageal cancer resection: a prospective population-based study in Sweden.
Viklund P, Lindblad M, Lu M, Ye W, Johansson J, Lagergren J
Ann Surg 2006 Feb;243(2):204-11

Carbonated soft drinks and risk of esophageal adenocarcinoma: a population-based case-control study.
Lagergren J, Viklund P, Jansson C
J Natl Cancer Inst 2006 Aug;98(16):1158-61

Controversies surrounding body mass, reflux, and risk of oesophageal adenocarcinoma.
Lagergren J
Lancet Oncol 2006 Apr;7(4):347-9

Gastric acid suppression and risk of oesophageal and gastric adenocarcinoma: a nested case control study in the UK.
García Rodríguez LA, Lagergren J, Lindblad M
Gut 2006 Nov;55(11):1538-44

Survival after surgery for oesophageal cancer: a population-based study.
Rouvelas I, Zeng W, Lindblad M, Viklund P, Ye W, Lagergren J
Lancet Oncol 2005 Nov;6(11):864-70

Adenocarcinoma of oesophagus: what exactly is the size of the problem and who is at risk?
Lagergren J
Gut 2005 Mar;54 Suppl 1():i1-5

Lifestyle related risk factors in the aetiology of gastro-oesophageal reflux
Nilsson M, Johnsen R, Ye W, Hveem K, Lagergren J
Gut 2004;53:1730-5

Helicobacter pylori infection and gastric atrophy: risk of adenocarcinoma and squamous-cell carcinoma of the esophagus and adenocarcinoma of the gastric cardia.
Ye W, Held M, Lagergren J, Engstrand L, Blot WJ, McLaughlin JK, Nyrén O
J Natl Cancer Inst 2004 Mar;96(5):388-96

Oesophageal cancer and gastro-oesophageal reflux: what is the relationship?
Lagergren J
Gut 2004 Aug;53(8):1064-5

Obesity and estrogen as risk factors for gastroesophageal reflux symptoms.
Nilsson M, Johnsen R, Ye W, Hveem K, Lagergren J
JAMA 2003 Jul;290(1):66-72

Screening and surveillance for Barrett esophagus in high-risk groups: a cost-utility analysis.
Inadomi JM, Sampliner R, Lagergren J, Lieberman D, Fendrick AM, Vakil N
Ann Intern Med 2003 Feb;138(3):176-86

Gastroesophageal reflux disease in monozygotic and dizygotic twins.
Cameron AJ, Lagergren J, Henriksson C, Nyren O, Locke GR, Pedersen NL
Gastroenterology 2002 Jan;122(1):55-9

Alcohol abuse and the risk of pancreatic cancer.
Ye W, Lagergren J, Weiderpass E, Nyrén O, Adami HO, Ekbom A
Gut 2002 Aug;51(2):236-9

Association between cholecystectomy and adenocarcinoma of the esophagus.
Freedman J, Ye W, Näslund E, Lagergren J
Gastroenterology 2001 Sep;121(3):548-53

Intestinal cancer after cholecystectomy: is bile involved in carcinogenesis?
Lagergren J, Ye W, Ekbom A
Gastroenterology 2001 Sep;121(3):542-7

Inverse association between intake of cereal fiber and risk of gastric cardia cancer.
Terry P, Lagergren J, Ye W, Wolk A, Nyrén O
Gastroenterology 2001 Feb;120(2):387-91

Risk of adenocarcinomas of the esophagus and gastric cardia in patients with gastroesophageal reflux diseases and after antireflux surgery.
Ye W, Chow WH, Lagergren J, Yin L, Nyrén O
Gastroenterology 2001 Dec;121(6):1286-93

Risk of pancreatic cancer after cholecystectomy: a cohort study in Sweden.
Ye W, Lagergren J, Nyrén O, Ekbom A
Gut 2001 Nov;49(5):678-81

Utility of endoscopic screening for upper gastrointestinal adenocarcinoma.
Lagergren J, Ye W, Bergström R, Nyrén O
JAMA ;284(8):961-2

Association between medications that relax the lower esophageal sphincter and risk for esophageal adenocarcinoma.
Lagergren J, Bergström R, Adami HO, Nyrén O
Ann Intern Med 2000 Aug;133(3):165-75

No relation between body mass and gastro-oesophageal reflux symptoms in a Swedish population based study.
Lagergren J, Bergström R, Nyrén O
Gut 2000 Jul;47(1):26-9

Human papillomavirus infection and esophageal cancer: a nationwide seroepidemiologic case-control study in Sweden.
Lagergren J, Wang Z, Bergström R, Dillner J, Nyrén O
J Natl Cancer Inst 1999 Jan;91(2):156-62

Association between body mass and adenocarcinoma of the esophagus and gastric cardia.
Lagergren J, Bergström R, Nyrén O
Ann Intern Med 1999 Jun;130(11):883-90

Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma.
Lagergren J, Bergström R, Lindgren A, Nyrén O
N Engl J Med 1999 Mar;340(11):825-31

No association between colon cancer and adenocarcinoma of the oesophagus in a population based cohort study in Sweden.
Lagergren J, Nyren O
Gut 1999 Jun;44(6):819-21

British Society of Gastroenterology guidelines on the diagnosis and management of Barrett's oesophagus.
Fitzgerald RC, di Pietro M, Ragunath K, Ang Y, Kang JY, Watson P, Trudgill N, Patel P, Kaye PV, Sanders S, O'Donovan M, Bird-Lieberman E, Bhandari P, Jankowski JA, Attwood S, Parsons SL, Loft D, Lagergren J, Moayyedi P, Lyratzopoulos G, de Caestecker J,
Gut 2014 Jan;63(1):7-42

The influence of preoperative weight loss on the postoperative course after esophageal cancer resection.
van der Schaaf MK, Tilanus HW, van Lanschot JJ, Johar AM, Lagergren P, Lagergren J, Wijnhoven BP
J Thorac Cardiovasc Surg 2014 Jan;147(1):490-5

Gastroesophageal reflux does not alter effects of body mass index on risk of esophageal adenocarcinoma.
Lagergren J, Mattsson F, Nyrén O
Clin Gastroenterol Hepatol 2014 Jan;12(1):45-51

Alla publicerade artiklar